ICCT logo

iCoreConnect Inc. (ICCT) Análisis de Acciones

Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

iCoreConnect Inc. (ICCT) opera en el sector Healthcare, cotizado por última vez a $ con una capitalización de mercado de 0. La acción obtiene una puntuación de 55/100, una calificación moderada basada en 9 KPI cuantitativos.

Ultimo analisis: 15 mar 2026
Puntuación de IA de 55/100

iCoreConnect Inc. (ICCT) Resumen de Asistencia Médica y Tuberías

CEOAdam V. Chambers
Empleados67
Sede CentralOcoee, US
Año de la oferta pública inicial (OPI)2023

iCoreConnect Inc. delivers HIPAA-compliant SaaS solutions for the healthcare industry, focusing on electronic prescriptions, insurance verification, and secure communication. With a negative profit margin and OTC market listing, the company faces challenges in a competitive landscape dominated by larger, more established players.

Procedencia de los datos | Datos financieros Análisis cuantitativo NASDAQ Análisis: 15 mar 2026

Tesis de Inversión

iCoreConnect operates in the growing healthcare information technology sector, offering a suite of HIPAA-compliant SaaS solutions. Key value drivers include the increasing adoption of electronic health records and the need for secure communication and data management in healthcare. However, the company's negative profit margin of -314.8% and OTC market listing present significant risks. Growth catalysts include expanding the customer base and introducing new product offerings. The company's ability to achieve profitability and gain market share in a competitive landscape will be critical to its long-term success.

Basado en las finanzas de FMP y el análisis cuantitativo

Puntos clave

  • iCoreConnect Inc. operates in the Healthcare Information Services industry, providing cloud-based SaaS solutions.
  • The company's gross margin stands at 72.1%, indicating a strong ability to control the direct costs associated with its services.
  • iCoreConnect has a negative P/E ratio of -0.00, reflecting its current lack of profitability.
  • The company's profit margin is -314.8%, indicating significant losses relative to its revenue.
  • iCoreConnect operates with 67 employees, reflecting its relatively small size compared to larger competitors.

Competidores y Pares

Fortalezas

  • HIPAA-compliant solutions.
  • Integrated suite of products.
  • Established presence in the healthcare IT market.
  • Specialized expertise in healthcare regulatory compliance.

Debilidades

  • Negative profit margin.
  • Limited financial resources.
  • Small market capitalization.
  • OTC market listing.

Catalizadores

  • Upcoming: Potential new partnerships with EHR vendors to expand market reach.
  • Ongoing: Increasing adoption of electronic health records and telehealth solutions.
  • Ongoing: Growing demand for HIPAA-compliant data security solutions in healthcare.

Riesgos

  • Potential: Intense competition from larger, more established players in the healthcare IT market.
  • Potential: Evolving healthcare regulations and compliance requirements.
  • Ongoing: Negative profit margin and limited financial resources.
  • Ongoing: OTC market listing and associated risks.

Oportunidades de crecimiento

  • Expansion of iCoreVerify and iCoreVerify+ adoption: The market for automated insurance eligibility verification is growing as healthcare providers seek to reduce claim denials and improve revenue cycle management. iCoreConnect can capitalize on this trend by expanding the features of iCoreVerify and targeting larger healthcare organizations. The market size for healthcare revenue cycle management is projected to reach $107.9 billion by 2029.
  • Increased adoption of iCoreExchange: With growing concerns about data privacy and security, the demand for HIPAA-compliant email solutions is increasing. iCoreConnect can promote iCoreExchange as a secure alternative to traditional email for healthcare professionals, targeting practices that handle sensitive patient information. The global healthcare cybersecurity market is projected to reach $38.5 billion by 2027.
  • Strategic partnerships with EHR vendors: Collaborating with established EHR vendors to integrate iCoreConnect's solutions into their platforms can provide access to a wider customer base and accelerate adoption. This strategy can leverage the existing infrastructure and relationships of EHR vendors to expand iCoreConnect's market reach.
  • Development of new SaaS solutions: Expanding the product portfolio with new SaaS solutions that address emerging needs in the healthcare industry can drive revenue growth and attract new customers. Potential areas for expansion include telehealth platforms, remote patient monitoring solutions, and data analytics tools for healthcare providers.
  • Geographic expansion: While currently focused on the United States, iCoreConnect can explore opportunities to expand its operations into other countries with similar healthcare regulations and market needs. This expansion can be achieved through partnerships with local distributors or by establishing a direct presence in new markets.

Oportunidades

  • Expansion of telehealth and remote patient monitoring.
  • Growing demand for data security and privacy solutions.
  • Strategic partnerships with EHR vendors.
  • Development of new SaaS solutions for healthcare providers.

Amenazas

  • Intense competition from larger, more established players.
  • Evolving healthcare regulations.
  • Cybersecurity threats and data breaches.
  • Economic downturn and reduced healthcare spending.

Ventajas competitivas

  • HIPAA compliance: iCoreConnect's focus on HIPAA compliance provides a competitive advantage in the healthcare industry, where data security and privacy are critical.
  • Integrated suite of solutions: The company offers a range of integrated solutions that address various needs of healthcare providers, creating a stickier customer base.
  • Established customer base: iCoreConnect has an existing customer base that provides a foundation for future growth.
  • Specialized expertise: The company has specialized expertise in healthcare IT and regulatory compliance.

Acerca de ICCT

Founded in 1992 and rebranded as iCoreConnect Inc. in 2017, the company offers a suite of cloud-based software solutions designed to address the specific needs of healthcare professionals. Their flagship products include iCoreRx, an electronic prescription software, and iCoreVerify, an insurance eligibility verification tool. iCoreConnect also provides solutions for prescription drug monitoring (iCorePDMP), secure email communication (iCoreExchange), cloud data backup (iCoreCloud), claims processing (iCoreClaims), and patient payment processing (iCorePay). iCoreConnect operates primarily in the United States, targeting healthcare providers seeking to improve efficiency and compliance with HIPAA regulations. The company's solutions aim to streamline administrative tasks, enhance patient care coordination, and improve revenue cycle management for healthcare practices.

Qué hacen

  • Provides HIPAA-compliant electronic prescription software (iCoreRx).
  • Offers a solution to check patient prescription drug history (iCorePDMP).
  • Provides automated insurance eligibility verification (iCoreVerify and iCoreVerify+).
  • Offers a tool to reveal the revenue potential of each patient (iCoreHuddle and iCoreHuddle+).
  • Provides a medical coding reference SaaS solution (iCoreCodeGenius).
  • Offers a secure email solution for healthcare professionals (iCoreExchange).
  • Provides cloud data backup services (iCoreCloud).
  • Offers claims processing and management solutions (iCoreClaims).

Modelo de Negocio

  • SaaS subscriptions: iCoreConnect generates revenue through recurring subscription fees for its various software solutions.
  • Per-transaction fees: Some services, such as claims processing and payment processing, may involve per-transaction fees.
  • Managed IT services: iCoreIT provides managed IT services to healthcare practices, generating revenue through service contracts.
  • Partnerships: Revenue may be generated through strategic partnerships with other healthcare technology vendors.

Contexto de la Industria

iCoreConnect operates within the healthcare information technology (IT) sector, which is experiencing significant growth driven by the increasing adoption of electronic health records (EHRs), the need for improved data security and compliance, and the growing demand for telehealth solutions. The market is competitive, with established players like ACNV (Accenture), CGHC (Cerner), EVLO (Evolus), HLTT (Hlth Corp), and INFIQ offering a range of healthcare IT solutions. iCoreConnect focuses on providing HIPAA-compliant SaaS solutions for specific healthcare needs, such as electronic prescriptions and insurance verification.

Clientes Clave

  • Small to medium-sized healthcare practices.
  • Dental practices.
  • Physicians and specialists.
  • Hospitals and clinics.
Confianza de la IA: 71% Actualizado: 15 mar 2026

Finanzas

Gráfico e información

Precio de la acción de iCoreConnect Inc. (ICCT): Price data unavailable

Últimas noticias

Consenso de analistas

Calificación de Consenso

Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para ICCT.

Objetivos de Precios

Análisis del precio objetivo de Wall Street para ICCT.

MoonshotScore

55/100

¿Qué significa esta puntuación?

El MoonshotScore califica el potencial de crecimiento de ICCT en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.

Liderazgo: Adam V. Chambers

CEO

Adam V. Chambers serves as the Chief Executive Officer of iCoreConnect Inc. His professional background and educational details are not available in the provided context. Further research would be required to provide a comprehensive overview of his career history, previous roles, and credentials.

Historial: Information regarding Adam V. Chambers' specific achievements, strategic decisions, and company milestones during his tenure as CEO of iCoreConnect Inc. is not available in the provided context. Further research would be required to assess his track record and contributions to the company's performance.

Información del mercado OTC de ICCT

The OTC Other tier represents the lowest tier of the OTC market, indicating that iCoreConnect Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it more difficult for investors to assess their financial health and performance. Investing in companies on the OTC Other tier carries a higher degree of risk compared to companies listed on major exchanges like the NYSE or NASDAQ.

  • Nivel OTC: OTC Other
  • Estado de divulgación: Unknown
Liquidez: Given the OTC Other listing, iCoreConnect's stock likely experiences lower trading volume and wider bid-ask spreads compared to stocks on major exchanges. This can make it more difficult to buy or sell shares quickly and at a desired price. Investors should be prepared for potential price volatility and limited liquidity when trading ICCT shares.
Factores de riesgo OTC:
  • Limited financial disclosure.
  • Low trading volume and liquidity.
  • Potential for price manipulation.
  • Higher risk of fraud or mismanagement.
  • Limited regulatory oversight.
Lista de verificación de diligencia debida:
  • Verify the company's financial statements and SEC filings (if any).
  • Research the background and experience of the company's management team.
  • Assess the company's business model and competitive landscape.
  • Evaluate the company's revenue and profitability trends.
  • Review the company's legal and regulatory compliance.
  • Consult with a financial advisor before investing.
  • Understand the risks associated with investing in OTC stocks.
Señales de legitimidad:
  • Company has been in business since 1992.
  • Offers a suite of HIPAA-compliant software solutions.
  • Focuses on a specific niche within the healthcare IT market.
  • Operates in a regulated industry (healthcare).

Lo Que los Inversores Preguntan Sobre iCoreConnect Inc. (ICCT)

¿Cuáles son los factores clave para evaluar ICCT?

iCoreConnect Inc. (ICCT) actualmente tiene una puntuación IA de 55/100, indicando puntuación moderada. Fortaleza clave: HIPAA-compliant solutions.. Riesgo principal a monitorear: Potential: Intense competition from larger, more established players in the healthcare IT market.. Esto no es asesoramiento financiero.

¿Qué es el MoonshotScore de ICCT?

ICCT actualmente puntúa 55/100 (Grado C) en el MoonshotScore, lo que sugiere calificación moderada. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.

¿Con qué frecuencia se actualizan los datos de ICCT?

Los precios de ICCT se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.

¿Qué dicen los analistas sobre ICCT?

La cobertura de analistas para ICCT incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.

¿Cuáles son los riesgos de invertir en ICCT?

Las categorías de riesgo para ICCT incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Intense competition from larger, more established players in the healthcare IT market.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.

¿Cuál es la relación P/E de ICCT?

La relación P/E para ICCT compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.

¿Está ICCT sobrevalorada o infravalorada?

Determinar si iCoreConnect Inc. (ICCT) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.

¿Cuál es el rendimiento por dividendo de ICCT?

iCoreConnect Inc. (ICCT) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.

Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.

Recursos Oficiales

Análisis actualizado el Puntuación de IA actualizada diariamente
Fuentes de Datos y Metodología
Datos de mercado proporcionados por Financial Modeling Prep y Yahoo Finance. Análisis de IA por algoritmos propietarios de Stock Expert AI. Indicadores técnicos mediante cálculos estándar de la industria. Última actualización: .

Datos proporcionados solo con fines informativos.

Notas de análisis
  • Financial data is based on the most recent available information.
  • OTC market data may be limited or less reliable than data for major exchanges.
  • AI analysis is pending and will provide further insights into the company's prospects.
Fuentes de datos

Popular Stocks